About Our Trials
The Liver Cancer Program (LCP) conducts clinical trials for patients with many different types of liver cancer, including hepatocellular carcinoma (the most common type of primary liver cancer) and cholangiocarcinoma (cancer that begins in the bile ducts). The NCI CLARITY study is a national collaborative network study on immunotherapy for liver cancer. You can see a complete list of our current clinical trials here.
If you are a patient interested in our clinical trials, please contact Donna Mabry at 240-858-3155 or email donna.mabry@nih.gov. Our care team contacts any prospective patients within 24 business hours after your call to collect basic information and give further instructions.
And you can find answers to frequently asked questions about clinical trials at CCR here.
Are Our Clinical Trials Right for You?
Second Opinions and Consultations
Seeking a second opinion? If you have recently been diagnosed or have been diagnosed in the past with a hepatocellular carcinoma or cholangiocellular carcinoma and would like to hear a second opinion, please email Dr. Cecilia Monge (cecilia.mongebonilla@nih.gov).
How to Refer a Patient
If you are a provider with a patient who may be a candidate for a trial, please contact Donna Mabry at 240-858-3155 or email donna.mabry@nih.gov.
Our care team contacts any prospective patients within 24 business hours after your call to collect basic information and give further instructions. We require a medical summary, operative notes, relevant radiographic scans (MRI, CT, PET), pathology report and additional materials as indicated.
With the patient’s permission, we keep their primary physician fully informed and involved in their care. After consultation, the physician (or nurse practitioner) will contact the patient's primary physician to coordinate care and follow-up plans.
Want to discuss a clinical case? If you have a difficult or interesting clinical case and would like to discuss treatment options with a hepatocellular carcinoma specialist, please contact us by email.
Clinical Team
Patient Referrals
Physicians
Interdisciplinary Tumor Review
All patients with primary liver cancer referred to the National Cancer Institute (NCI) are discussed by an interdisciplinary tumor board to identify the best and most effective treatment options for them. The tumor board consists of experts in liver cancer research and treatment, including:
- Dr. Brad Wood, Interventional Radiology
- Dr. Tim Greten, Medical Oncology
- Dr. Jake Liang, Hepatology
- Dr. Jonathan Hernandez, Surgery
- Dr. David Kleiner, Pathology
- Dr. Theo Heller, Hepatology
The NIH Clinical Center
Many of the LCP’s clinical trials take place at the NIH Clinical Center in Bethesda, Maryland. You can learn more about the NIH Clinical Center and the clinical trials that are run there here.
Educational Resources
Learn more about liver cancer by visiting the National Cancer Institute page on this disease.
Clinical Training
Visit Clinical Training Opportunities to learn more about clinical training programs at the NCI Center for Cancer Research.